Plain-English translation of NCT07308639 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study uses existing health records from Germany to learn how common three eye diseases are: age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). Researchers will look at data collected over 15 years to understand how many people have these conditions, whether certain groups are more likely to develop them, and how they're being treated with a medication called anti-VEGF.
These three eye diseases can cause serious vision loss, but we don't have a clear picture of how often they occur in Germany or how well current treatments are working. This study will help doctors and health officials understand the real-world impact of these diseases and guide better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You won't need to visit a clinic or take any new medication. Instead, researchers will use your existing health records that are already stored in German healthcare databases. They'll analyze this information to track your eye disease diagnosis, treatments you received, and outcomes over time. Your participation is passive — the study uses data already collected as part of your routine care.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Germany